Lipid nanoparticle-based mRNA candidates elicit potent T cell responses.
暂无分享,去创建一个
[1] T. Sharp,et al. Anionic Lipid Nanoparticles Preferentially Deliver mRNA to the Hepatic Reticuloendothelial System , 2022, Advanced materials.
[2] Yizhou Dong,et al. Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications. , 2021, Accounts of chemical research.
[3] S. D. De Smedt,et al. The dawn of mRNA vaccines: The COVID-19 case , 2021, Journal of Controlled Release.
[4] Siddharth Patel,et al. Deconvoluting Lipid Nanoparticle Structure for Messenger RNA Delivery , 2020, Nano letters.
[5] D. Weissman,et al. A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice. , 2020, Molecular therapy : the journal of the American Society of Gene Therapy.
[6] Martha E. Zeeman,et al. Human chimeric antigen receptor macrophages for cancer immunotherapy , 2020, Nature Biotechnology.
[7] Qiang Cheng,et al. Selective ORgan Targeting (SORT) nanoparticles for tissue specific mRNA delivery and CRISPR/Cas gene editing , 2020, Nature Nanotechnology.
[8] Siddharth Patel,et al. Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA , 2020, Nature Communications.
[9] Michael J. Mitchell,et al. Ionizable Lipid Nanoparticle Mediated mRNA Delivery for Human CAR T Cell Engineering. , 2020, Nano letters.
[10] M. Manoharan,et al. The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs , 2019, Nature Nanotechnology.
[11] Robert Langer,et al. Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation , 2019, Nature Biotechnology.
[12] Daniel G Anderson,et al. Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.
[13] D. Weissman,et al. Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques , 2019, Molecular therapy. Nucleic acids.
[14] G. Ebel,et al. An mRNA Vaccine Protects Mice against Multiple Tick-Transmitted Flavivirus Infections , 2018, Cell Reports.
[15] Florian Krammer,et al. Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies , 2018, Nature Communications.
[16] J. Bluestone,et al. Revisiting IL-2: Biology and therapeutic prospects , 2018, Science Immunology.
[17] Örn Almarsson,et al. A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.
[18] D. Weissman,et al. mRNA vaccines — a new era in vaccinology , 2018, Nature Reviews Drug Discovery.
[19] Kimberly J. Hassett,et al. Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.
[20] Justin M. Richner,et al. Modified mRNA Vaccines Protect against Zika Virus Infection , 2017, Cell.
[21] Robert Langer,et al. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. , 2017, Nano letters.
[22] D. Weissman,et al. Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge , 2017, Nature Communications.
[23] D. Weissman,et al. Zika virus protection by a single low dose nucleoside modified mRNA vaccination , 2017, Nature.
[24] J. Rosenecker,et al. Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems , 2017, Gene Therapy.
[25] S. Kaech,et al. The multifaceted role of CD4+ T cells in CD8+ T cell memory , 2016, Nature Reviews Immunology.
[26] Daniel G. Anderson,et al. Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs. , 2015, Nano letters.
[27] T. Schlake,et al. Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.
[28] D. O’Sullivan,et al. Expanding the role of metabolism in T cells , 2015, Science.
[29] Özlem Türeci,et al. mRNA-based therapeutics — developing a new class of drugs , 2014, Nature Reviews Drug Discovery.
[30] Daniel G. Anderson,et al. Non-viral vectors for gene-based therapy , 2014, Nature Reviews Genetics.
[31] Robert Langer,et al. Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates , 2014, Proceedings of the National Academy of Sciences.
[32] Michael J. Bevan,et al. CD8+ T Cells: Foot Soldiers of the Immune System , 2011, Immunity.
[33] K. G. Rajeev,et al. Rational design of cationic lipids for siRNA delivery , 2010, Nature Biotechnology.
[34] M. Bevan,et al. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. , 2010, Immunity.
[35] Kathryn A. Whitehead,et al. Lipid-like materials for low-dose, in vivo gene silencing , 2010, Proceedings of the National Academy of Sciences.
[36] Hiroki Kato,et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[37] V. Appay,et al. CD8+ T cell efficacy in vaccination and disease , 2008, Nature Medicine.
[38] J. Sprent,et al. Selective Stimulation of T Cell Subsets with Antibody-Cytokine Immune Complexes , 2006, Science.
[39] G. Trinchieri,et al. Interleukin-12 and the regulation of innate resistance and adaptive immunity , 2003, Nature Reviews Immunology.
[40] T Salditt,et al. An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. , 1998, Science.